Providers Clinical Support System Substance Use Disorder Treatment (PCSS-SUD Treatment)

The Providers Clinical Support System – Substance Use Disorder Treatment (PCSS-SUD Treatment) initiative is a federal funding opportunity administered by the Substance Abuse and Mental Health Services Administration (SAMHSA), a division of the U.S. Department of Health and Human Services. SAMHSA plays a key role in improving access to behavioral health services and treatment for individuals affected by mental health and substance use disorders. This grant initiative continues SAMHSA's commitment to expanding capacity and expertise among healthcare providers who engage with individuals at risk for or experiencing substance use disorders (SUDs), with a particular emphasis on opioid and alcohol use disorders. The primary objective of the PCSS-SUD Treatment program is to strengthen and expand training, technical assistance (TTA), and mentorship to healthcare professionals operating in general health and behavioral health care settings. Through this initiative, SAMHSA aims to increase the number of practitioners equipped with the skills, knowledge, and support systems needed to identify, assess, and treat substance use disorders. By focusing on clinical support, the program intends to foster comprehensive and integrated approaches to SUD treatment within the broader health care delivery system. The program is structured as a cooperative agreement, indicating a significant level of federal involvement in the administration and implementation of the funded project. Funding is expected to total approximately $3 million, with one award anticipated for this cycle. Allowable expenditures under this funding likely include staffing for technical assistance delivery, development and distribution of clinical training materials, outreach and coordination with professional organizations, and ongoing mentoring of providers in the field. While specific cost limitations or indirect cost caps are not stated in the forecast, typical cooperative agreement expectations and oversight will apply. Eligibility for the PCSS-SUD Treatment funding is open to a range of domestic public and private nonprofit entities. This includes professional organizations, particularly those identified in the Medication Access and Training Expansion (MATE) Act. The eligibility scope is inclusive, and there are no geographic limitations mentioned in the forecast, suggesting national applicability. Applicants must be nonprofit entities and should demonstrate organizational capacity and experience in providing clinical training, technical assistance, and mentorship to healthcare professionals. The opportunity is currently in a forecast stage, with an estimated posting date of April 15, 2026. No application due date or project start date is listed yet, and no pre-application requirements such as Letters of Intent or concept papers are indicated in the available forecast data. Once the Notice of Funding Opportunity (NOFO) is officially released, prospective applicants should monitor for specific requirements regarding submission methods, content of proposals, and application components. For inquiries related to this forecasted opportunity, the listed contact is Belinda Greenfield, who can be reached by phone at (240) 276-2545 or via email at [email protected]. Given that this is a forecasted opportunity, all dates are subject to change. Organizations interested in applying should continue monitoring Grants.gov and SAMHSA’s website for updates, including the release of a full NOFO that will outline evaluation criteria, performance period expectations, and final deadlines.